Aquilo Capital Management as of Dec. 31, 2019
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 12 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 44.6 | $119M | 1.3M | 95.11 | |
| Uniqure Nv (QURE) | 10.7 | $28M | 397k | 71.66 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 7.2 | $19M | 1.9M | 9.91 | |
| Pieris Pharmaceuticals | 6.7 | $18M | 5.0M | 3.58 | |
| Xenon Pharmaceuticals (XENE) | 5.8 | $15M | 1.2M | 13.11 | |
| Galapagos Nv- (GLPG) | 5.6 | $15M | 72k | 206.83 | |
| Merus N V (MRUS) | 5.5 | $15M | 1.0M | 14.08 | |
| Dicerna Pharmaceuticals | 5.1 | $14M | 614k | 22.03 | |
| Spero Therapeutics (SPRO) | 4.2 | $11M | 1.2M | 9.61 | |
| Regenxbio Inc equity us cm (RGNX) | 4.1 | $11M | 269k | 40.97 | |
| Fate Therapeutics (FATE) | 0.5 | $1.4M | 72k | 19.56 | |
| Morphosys (MOR) | 0.1 | $217k | 6.1k | 35.69 |
